Literature DB >> 8237588

Effects of cocaine on the respiratory burst of murine macrophages.

A Vaz1, S S Lefkowitz, D L Lefkowitz.   

Abstract

Cocaine is a central nervous stimulant with a major potential for abuse. It is used clinically as a local anesthetic and vasoconstrictor. The effects of cocaine on the immune system have not been studied in depth. In this study, we have investigated the effects of cocaine on the respiratory burst (RB) of murine macrophages (M phi). The RB was measured by determining the increase in chemiluminescence. Both peritoneal and alveolar M phi were isolated from cocaine-exposed mice and saline-exposed controls. Cocaine was administered by the intraperitoneal, intravenous, and intramuscular route. Both peritoneal and alveolar M phi from cocaine-exposed mice showed an increase in chemiluminescence when compared with M phi from matched controls. This effect was seen as early as one hour after cocaine exposure and lasted for up to 48 hours. Intraperitoneal injection of cocaine metabolites did not affect the RB. Macrophages exposed to cocaine in vitro failed to respond by an increase in RB. These findings indicate that cocaine induces the production of reactive oxygen intermediates (ROI) and suggests possible changes in M phi functions.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8237588     DOI: 10.1007/978-1-4615-2980-4_19

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  2 in total

1.  Cocaine causes increased type I interferon secretion by both L929 cells and murine macrophages.

Authors:  K Grattendick; D B Jansen; D L Lefkowitz; S S Lefkowitz
Journal:  Clin Diagn Lab Immunol       Date:  2000-03

2.  Oral Enrichment of Streptococcus and its Role in Systemic Inflammation Related to Monocyte Activation in Humans with Cocaine Use Disorder.

Authors:  Xiaoyu Fu; Da Cheng; Zhenwu Luo; Amanda Wagner; Sylvia Fitting; Xiaomei Cong; Wanli Xu; Kendra Maas; Zhuang Wan; Jian Zhu; Zejun Zhou; William W Stoops; Aimee McRae-Clark; Wei Jiang
Journal:  J Neuroimmune Pharmacol       Date:  2021-08-26       Impact factor: 7.285

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.